Article

Overexpressed FAM166B Predicts Favorable Prognosis and Associated With Metabolic Pathways and Tumor Immune Infiltrates in BRCA

2021-06-30

Abstract excerpt

<h4>Background: </h4> Breast cancer is one of the most common and lethal cancer worldwide. Though surgery, chemotherapy, endocrine therapy and immune therapy have boost patients' survival rate, to establish more molecular biomarkers that can detect the early metastasis and shed a light on breast cancer treatment still requires efforts. Based on previous studies, adipose tissue had a metabolic crosstalk in breast c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 58383602-4854-5b4f-bb4f-92cecd8af41f
DOI: 10.21203/rs.3.rs-573756/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Overexpressed FAM166B Predicts Favorable Prognosis and Associated With Metabolic Pathways and Tumor Immune Infiltrates in BRCADOI 10.21203/rs.3.rs-573756/v1Read

Development of a novel lipid metabolism-based signature to predict survival and immune response in triple negative breast cancerSemantic proximity Read

Transcriptomic analysis identified new lipid biomarkers for patient stratification in breast cancerSemantic proximity Read

Breast cancer metabolic subtypes analysis and risk prognostic models construction based on glycolysis metabolism genesSemantic proximity Read

Genetic identification of the m6A-related gene YTHDF3 as a putative biomarker for breast cancerSemantic proximity Read

Correlation between metabolic characteristics and breast cancer subtypes and prognosisSemantic proximity Read

PMAIP1-Mediated Glucose Metabolism and its Impact on the Tumor Microenvironment in Breast Cancer: Integration of Multi-Omics Analysis and Experimental ValidationSemantic proximity Read

Identification of lipid droplet-associated genes in breast cancer patientsSemantic proximity Read

FAM155B driven by BPTF promotes breast cancer progression and paclitaxel resistance via SREBP1-mediated fatty acid metabolic reprogrammingSemantic proximity Read

Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast CancerSemantic proximity Read

Development and Validation of a Prognostic Classifier Based on Metabolism-Related Genes for Breast CancerSemantic proximity Read

Prognostic Value of IGFBP6 in Breast Cancer: Focus on GlucometabolicSemantic proximity Read

Systematic analysis of fatty acid desaturases in breast invasive carcinoma: The prognosis, gene mutation, and tumor immune microenvironment.Semantic proximity Read